GLOWSCREEN

supergoop, llc🇨🇦 Health Canada

Approval Id: f96250e2dae52359
Drug Approval Canada Name: GLOWSCREEN
Product Name: GLOWSCREEN
Status: Marketed
Status Date: 2023-03-13
Original Market Date: 2021-01-26
Din: 02503107
Drug Class: Human
Dosage Form: Lotion
Route Of Administration: Topical
Schedule: OTC
Ahfs: 84:80.00
Atc Original: D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Atc Name: d 02 ba 30
Aig Number: 0335121001
Company Name: supergoop, llc
Company Address: 200 E. Grayson, Suite 110, San Antonio, Texas, United States

AVOBENZONE

3 % / W/W

OCTISALATE

5 % / W/W

OCTOCRYLENE

10 % / W/W

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f96250e2dae52359

Type

Standard